Lipoprotein(a) in 505 hospitalized patients with various pathological states: Correlations with cardiovascular diseases and therapies

International Angiology

Volumn 15, Issue 1, 1996, Pages 1-5

  Constans, J ^a   Wendling, G ^b   Peuchant, E ^a   Camilleri, G ^b   Conri, C ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

^b centre hospitalier de Bayeux   (France)

Author keywords

Atherosclerosis; Inflammation; Lipoprotein (a)

Indexed keywords

ACUTE PHASE PROTEIN; AMINOTRANSFERASE; ANTITHROMBOCYTIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM ALBUMIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CANCER; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INFECTION; MAJOR CLINICAL STUDY; MALE; PROTEINURIA; SYSTEMIC DISEASE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

ADULT; AGED; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL; DIABETES MELLITUS; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION; INFECTION; LIPOPROTEIN(A); MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES;

EID: 0029991296     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Berg K. A New serum type system in man. The Lp system. Acta Pathol Microbiol Scand 1963;59:369-82.
2. Kostner GM, Avogaro P, Cazzolato G et al. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981;38:51-68.
3. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc 1986;256: 2540-4.
4. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J 1990;301: 1248-51.
5. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein (a) and the risk of myocardial infarction. J Am Med Assoc 1993;270:2195.
6. Krempler F, Kostler GM, Bolzano K, Sandhofer H. Turnover of lipoprotein (a) in man. J Clin Invest 1980; 65:1483-90.
7. Gaubatz JW, Khanem KI, Guevara J, Nava ML, Patsch W, Morrisett JD. Polymorphic forms of human apolipoprotein (a): inheritance and relationship of their molecular weights to plasma levels of lipoprotein (a). J Lipid Res 1990;31:603-13.
8. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a) lipoprotein plasma concentrations in plasma. J Clin Invest 1987; 80:458-65.
9. Steinmetz J, Tarolo P, Fournier B et al. Valeurs de référence de la lipoprotéine (a) dans la population française. Presse Méd 1994;23:1695-8.
10. Seed M, Hoppichler F, Reaveley D et al. Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 1990;322:1494-9.
11. Dahlen GH, Guyton JR, Attar M, Farer JA, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein (a), plasma lipids and other lipoproteins with coronary artery disease documented by angioaraphy. Circulation 1986;74:758-65.
12. Zenker G, Koltringer P, Bone G, Niederkorn K, Pfeiffer K, Jürgens G. Lipoprotein (a) as a strong indicator for cerebrovascular disease. Stroke 1986;17:758-65.
13. Murai A, Miyahara T, Fujimoto KN, Matsuda M, Kanmeyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986; 59:199-204.
14. Ettingin OR, Hajjar DP, Hajjar KA, Harpel PC, Nachman RL. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. J Biol Chem 1991;266:2459-65.
15. Edelberg JM, Gonzales-Gronow M, Pizzo SV. Lipoprotein (a) inhibits strptokinase-mediated activation of human plasminogen. Biochemistry 1989;28:2370-4.
16. Dahlen GH. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 1994:111-26.
17. Jenner JL, Ordovas JM, Lamon-Fava S et al. Effects of age, sex and menopausal status on plasma lipoprotein (a) levels: the Framingham offspring study. Circulation 1993;87:1135-41.
18. Nabulsi AA, Folsom AR, Whita A, Patsch W, Heiss G, Wu KK. Association of hormone-replacement therapy with various cardiovascular risk factors in post-menopausal women. N Egnl J Med 1993;328:1069-75.
19. Carlson LA, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipaemic subjects treated with nicotinic acid. J Intern Med 1989;226:271-6.
20. Srinavasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS. Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Bogalus heart study. Circulation 1991;84:160-7.
21. Helmhold M, Bigge J, Muche R et al. Concentration of the apo(a) phenotype to plasma Lp(a) concentrations shows considerable ethnic variation. J Lipid Res 1991;32:1939-28.
22. Haffner SM, Tuttle KR, Rainwater DL. Decrease of lipoprotein (a) with improved glycemic control in IDDM subjects. Diabetes Care 1991;14:302-7.
23. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein (a) as an acute phase protein. Atherosclerosis 1989; 78:145-50.
24. Rantapää-Dahlqvist S, Wallberg-Jonsson S, Dahlen GH. Lipoprotein (a), lipids and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 1991; 50:366-8.
25. Simon JP, Vanco G. Elévation de la lipoprotéine (a) au cours d'une maladie de Horton (letter). Presse Méd, 1993;22:1835.
26. Grunfeld C, Feingold KR. Tumor necrosis factor, cytokines, and the hyperlipidemia of infection. Trends Endocrinol Metab 1991;2:213-9.
27. Constans J, Pellegrin JL, Peuchant E et al. High plasma lipoprotein (a) in HIV-positive patients. Lancet 1993;341:1099-100.